Client News

DSS Inc. (NASDAQ: DSS) Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc.

ROCHESTER, N.Y., July 05, 2023 (GLOBE NEWSWIRE) — DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce the appointment of Daniel Lew as Chief Investment Officer and Portfolio Manager. With over three decades of experience in investment management, security analysis, and institutional client […]

Bradley Runkel Promoted to Vice President of the Service Partner Network by Laser Photonics Corporation (NASDAQ: LASE)

ORLANDO, Fla., July 04, 2023–(BUSINESS WIRE)–Laser Photonics Corporation (NASDAQ: LASE) announced that today, Bradley Runkel was promoted from sales engineer to the vice president of its Service Partner Network (SPN) program to assist in its management, growth and development as it continues to spread across the United States. Bradley Runkel, Vice President of the Service […]

Laser Photonics (NASDAQ: LASE) CleanTech: The Solution to Tire Mold Cleaning

ORLANDO, Fla., July 03, 2023–(BUSINESS WIRE)–Laser Photonics Corporation (NASDAQ: LASE), a leading global industrial developer of CleanTech laser systems for laser cleaning and other material applications, announces a key application for its CleanTech laser system – tire mold cleaning. CleanTech technology provides manufacturers with a cost-effective and eco-friendly method of removing contaminants from the molds […]

DSS Inc. (NYSE American: DSS) Announces Updated Shareholder of Record Date for Spinoff of Impact BioMedical Inc.

Shareholders of Record on July 10, 2023 to Receive Four Shares of Impact Biomedical Inc. for Every One Share of DSS, Inc. on a Future Distribution Date ROCHESTER, N.Y., June 30, 2023 (GLOBE NEWSWIRE) — DSS, Inc. (“DSS” or the “Company”) (NYSE American: DSS), a multinational company operating nine business divisions through strategic acquisitions and […]

Scott Smiley Hired as Technical Sales Representative by Laser Photonics Corporation (NASDAQ: LASE)

ORLANDO, Fla., June 30, 2023–(BUSINESS WIRE)–Laser Photonics Corporation (NASDAQ: LASE), a leading global developer of CleanTech laser systems for laser cleaning and other material applications, today announced that it hired Scott Smiley as its technical sales representative. Scott Smiley, a newly hired technical sales representative of Laser Photonics, commented, “I look forward to working with Laser […]

Laser Photonics (NASDAQ:LASE) Introduces New DefenseTech Line of Products to Address the Defense Industry’s MRO Needs

DefenseTech product line to target multibillion dollar MRO opportunity in the defense industry ORLANDO, FL / ACCESSWIRE / June 29, 2023 / Laser Photonics Corporation (NASDAQ:LASE), a leading global industrial developer of CleanTech laser systems for laser cleaning and other material applications, today introduced its DefenseTech line of products to tackle the MRO needs of the […]

NanoViricides (NYSE American:NNVC)  Announces that Clinical Trials of Its Broad-Spectrum Antiviral Drug NV-CoV-2 Have Begun

SHELTON, CT / ACCESSWIRE / June 29, 2023 / NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) reports that clinical trials of its broad-spectrum antiviral drug NV-CoV-2 began on June 17, 2023 with two oral drug products: (i) NV-CoV-2 Oral Syrup, and (ii) NV-CoV-2 Oral Gummies. “We believe that the start of the Phase 1a/1b safety and efficacy clinical […]

Organicell (OTCQB:OCEL) Welcomes Howard Golub, MD, PhD As Its New EVP/CSO

FORT LAUDERDALE, FL / ACCESSWIRE / June 29, 2023 / Organicell Regenerative Medicine, Inc. (OTCQB:OCEL), a clinical-stage biopharmaceutical company focused on the development of innovative biological regenerative therapeutics, is pleased to announce the appointment of Howard L. Golub, MD, PhD as its new Executive Vice President (EVP) and Chief Science Officer (CSO). Dr. Golub has […]

Longeveron (NASDAQ: LGVN) Files Registration Statement for Rights Offering

MIAMI, June 27, 2023 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN) (“Longeveron” or “Company”), a clinical stage biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions such as Alzheimer’s Disease and Aging Frailty, announced today that it has filed a registration statement with the Securities and Exchange Commission (“SEC”) to conduct a tradeable […]

Start Expanding
Your Shareholder Base

Let us help you connect with investors
committed to your success.